Investments in progress
We are out there looking for the next big thing or at the office analyzing, verifying the facts, and drafting agreements. Sign up and we will let you know once have found something great.
Our portfolio companies
Our portfolio companies are currently developing diagnostics for early detection of cancer via blood sample, saving lives in emergency care and surgery through software innovations, developing personalised treatments of severe diseases, and much more.
MedFilm
MedFilm offers a subscription service for animated information videos about surgical procedures. With the videos, surgery clinics can easily provide patients with information before surgery.
1928 Diagnostics
1928 Diagnostics is fighting against the global threat of resistant bacteria by offering software for the quick and effective diagnose of bacterial infections. The software is offered as a software-as-a-service and in combination with hardware already used in hospitals it provided detailed information regarding bacteria and their resistance profiles.
Likvor
Likvor offers a CE-certified system helping healthcare personnel to diagnose normal pressure hydrocephalus (NPH) which is a very under diagnosed condition with dementia-like symptoms.
Exits
Former portfolio companies that have reached new heights through acquisition or listing, and continue to thrive under new ownership. These companies continue to make a lasting impact in their respective industries.
Lipigon Pharmaceuticals
Lipigon develops orphan drugs for illnesses due to disorders in how the body handles fat. The company’s major program, Lipsense, focuses on the illness, HoFH, where there is, today, no sufficient treatment.
Read more
Inhalation Sciences
Inhalation Science’s technology is used by leading players in the chemical and pharmaceutical sectors to study how airborne particles affect the human body.
Read more